Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: Thomas Forst, Prof. Dr
Woman and Man Max 99 years
Thomas Forst, Prof. Dr
Update Il y a 4 ans
Impact of Liraglutide on Endothelial Function and Microvascular Blood Flow in Type 2 Diabetes Mellitus
The trial is a phase IV clinical trial investigating the impact of Liraglutide on endothelial function and microvascular blood flow in 44 patients with type 2 diabetes mellitus aged 30-65 ...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Thomas Forst, Prof. Dr
Update Il y a 4 ans
Safety and Efficacy of GRT6005 in Pain Due to Diabetic Polyneuropathy
The purpose of this trial is to investigate the efficacy and safety of GRT6005 in patients with painful diabetic neuropathy.
Country
Bulgaria
,
Germany
,
Romania
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Thomas Forst, Prof. Dr
Update Il y a 4 ans
Saxagliptin in Combination With Dapagliflozin - Effects on Islet Cell Function
The purpose of this study is to evaluate alpha- and beta-cell function during combination treatment with saxagliptin in addition to dapagliflozin and metformin compared to placebo in addit...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Thomas Forst, Prof. Dr. med
Update Il y a 4 ans
Painful Diabetic Polyneuropathy Trial With a New Centrally Acting Analgesic
The purpose of this trial is to determine whether the new centrally active analgesic and MS Continus® are effective in the treatment of painful diabetic polyneuropathy.
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Thomas Forst, Prof. Dr
Update Il y a 4 ans
Effect of Adding Vildagliptin on Beta Cell Function and Cardiovascular Risk Markers in Patients With Moderate Metabolic Control During Metformin Monotherapy
The aim of this pilot-study is to investigate the effect of Vildagliptin in comparison to glimepiride on beta cell function and the cardiovascular risk profile in patients previously treat...
Country
None
organs
None
Specialty
None
unknown
More information